Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-05-27 @ 7:59 PM
Study NCT ID:
NCT06958705
Status:
RECRUITING
Last Update Posted:
2025-11-25
First Post:
2025-04-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2024-SR-1147
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |